Prognosis
Moderna Shot Effective in Teens, Opening Path for Clearances
- Company will submit for regulatory authorization in early June
- Shot was 93% to 100% effective in study of 12 to 17 year olds
This article is for subscribers only.
Moderna Inc.’s Covid-19 vaccine was highly effective in 12 to 17 year-old adolescents in a large study, paving the way for regulatory submissions around the world by early June.
In a news release, the company said its vaccine was between 93% and 100% effective in preventing symptomatic Covid in a study of teenagers, depending on whether very mild cases are included in the count. The study met its primary goal of showing that immune responses to the vaccine in 12 to 17 year-olds were as good as those produced in adults, and no significant safety concerns were observed, according to the company.